FDA Approves BELSOMRA® (suvorexant) for the Treatment of Insomnia

August 13, 2014 8:52 PM

49 0

BELSOMRA expected to be available in late 2014 or early 2015

WHITEHOUSE STATION, N.J., Aug 13, 2014 (BUSINESS WIRE) -- Merck /quotes/zigman/574389/delayed MRK +1.44% , known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved BELSOMRA® (suvorexant) for adults with insomnia who have difficu...

Read more

To category page